Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liana Nikolaenko

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Future Oncology (London, England)|July 18, 2020
Brentuximab vedotin and its use in the treatment of advanced Hodgkin's lymphomaLiana Nikolaenko, Auayporn Nademanee
Current Hematologic Malignancy Reports|November 20, 2019
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative DisordersGeoffrey Shouse, Liana Nikolaenko
Expert Review of Anticancer Therapy|January 27, 2021
Duvelisib (Copiktra) in relapsed or refractory chronic lymphocytic leukemia: safety and efficacyLiana Nikolaenko, Tingting Liu, Alexey V Danilov
Therapeutic Advances in Hematology|October 21, 2017
Current strategies for salvage treatment for relapsed classical Hodgkin lymphomaLiana Nikolaenko, Robert Chen, Alex F Herrera
The Journal of Family Planning and Reproductive Health Care|June 20, 2013
Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findingsRowan T Chlebowski, Liana Nikolaenko, Garnet Anderson
Molecular Therapy. Nucleic Acids|January 30, 2017
Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide DrugsCy Stein, Daniela Castanotto, Amrita Krishnan, et al.
Cancer Treatment and Research|January 1, 2019
CD30-Positive Lymphoproliferative DisordersLiana Nikolaenko, Jasmine Zain, Steven T Rosen, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic TransplantationLiana Nikolaenko, Saurabh Chhabra, Noa Biran, et al.
Journal of Lipid Research|September 30, 2011
Turnover of nonessential fatty acids in cardiolipin from the rat heartPaulin N Wahjudi, Jennifer K Yee, Steven R Martinez, et al.
British Journal of Haematology|November 19, 2025
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II studySwetha Kambhampati Thiruvengadam, Leslie L Popplewell, Alex F Herrera, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Future Oncology (London, England)|July 18, 2020
Brentuximab vedotin and its use in the treatment of advanced Hodgkin's lymphomaLiana Nikolaenko, Auayporn Nademanee
Current Hematologic Malignancy Reports|November 20, 2019
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative DisordersGeoffrey Shouse, Liana Nikolaenko
Expert Review of Anticancer Therapy|January 27, 2021
Duvelisib (Copiktra) in relapsed or refractory chronic lymphocytic leukemia: safety and efficacyLiana Nikolaenko, Tingting Liu, Alexey V Danilov
Therapeutic Advances in Hematology|October 21, 2017
Current strategies for salvage treatment for relapsed classical Hodgkin lymphomaLiana Nikolaenko, Robert Chen, Alex F Herrera
The Journal of Family Planning and Reproductive Health Care|June 20, 2013
Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findingsRowan T Chlebowski, Liana Nikolaenko, Garnet Anderson
Molecular Therapy. Nucleic Acids|January 30, 2017
Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide DrugsCy Stein, Daniela Castanotto, Amrita Krishnan, et al.
Cancer Treatment and Research|January 1, 2019
CD30-Positive Lymphoproliferative DisordersLiana Nikolaenko, Jasmine Zain, Steven T Rosen, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 7, 2020
Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic TransplantationLiana Nikolaenko, Saurabh Chhabra, Noa Biran, et al.
Journal of Lipid Research|September 30, 2011
Turnover of nonessential fatty acids in cardiolipin from the rat heartPaulin N Wahjudi, Jennifer K Yee, Steven R Martinez, et al.
British Journal of Haematology|November 19, 2025
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II studySwetha Kambhampati Thiruvengadam, Leslie L Popplewell, Alex F Herrera, et al.
Pageof 3